References
- Choi S, Lagakos SW, Schooley RT, et al. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med 1993; 118(9): 674–80
- NIAID issues preliminary recommendations on antiretrovirals. AIDS Clin Care 1993; 6(8): 64–5
- Hirsch MS, D'Aquila RT. Therapy for human immunodeficiency virus infection. N Engl J Med 1993; 328(23): 1686–95
- Aboulker JP, Swart AM. Preliminary analysis of the Concorde trial: Concorde Coordinating Committee. (Letter) Lancet 1993; 341(8849): 889–90
- Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322(14): 941–9
- Cooper DA, Gatell JM, Kroon S, et al. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993; 329(5): 297–303
- Hamilton JD, Harrigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med 1992; 326(7): 437–43
- Velia S, Giuliano M, Pezzetti P, et al. Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. JAMA 1992; 267(9): 1232–6
- Edlin BR, St Clair MH, Pitha PM, et al. In-vitro resistance to zidovudine and alphainterferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med 1992; 117(6): 457–60 [erratum, Ann Intern Med 1992; 117(10): 879]
- Erice A, Mayers DL, Strike DG, et al. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993; 328(16): 1163–5
- Kahn JO, Lagakos SW, Richman DD, et al. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med 1992; 327(9): 581–7
- Meng TC, Fischl MA, Boota AM, et al. Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection: a phase I/II study. Ann Intern Med 1992; 116(1): 13–20
- Skowron G, Bozzette SA, Lim L, et al. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex. Ann Intern Med 1993; 118(5): 321–30
- Collier A, Henry K, Japour A, et al. Switching and combining antiretroviral therapies. AIDS Clin Care 1993; 5(5): 33–7